17 September 2014Presentation of AIS Channel in Barcelona
A group of world-renowned surgeons has presented in Barcelona the AIS Channel (Advances In Surgery), an interactive online platform for sharing technical innovations in the surgical field.
16 September 2014The AirSeal® iFS System has been tested for TAMIS procedure
Smoke is an important issue that comes out when surgeons with experience in the transanal approach for rectal diseases discuss the pitfalls and limitations of this technique. Different strategies have been proved without satisfactory results, recently a new device, based on Dr. Joep Knol’s idea, was tested for transanal procedure with good results.
12 September 2014Status Quo of Metabolic Surgery
Nowadays there is a lot of data concerning the treatment of morbid obesity and its comorbidities, this fact leads to several questions such as how to define the surgical treatment: Bariatric or metabolic? Which one is the best? Hormonal changes, what is the impact? Get in to the 5th AIS The Truth about Metabolic Surgery for all the details.
11 September 2014Cherry pit bezoar: a rare cause of ileal sub-occlusion
Subocclusion is a frequent pathology in the emergency room usually due to post-surgical adhesions but occasionally, other unexpected etiologies are discovered. This picture shows a phytobezoar as one of those rare causes.
10 September 2014IFSO14 Live surgery session: Sleeve gastrectomy for T2DM
The 19th world congress of the International Federation for the Surgery of Obesity and Metabolic Disorders was celebrated at Montreal, one of the main activities of this event was a concurrent, multi country debate focused in the Sleeve gastrectomy, a popular procedure for the treatment of morbid obese patient and its morbidities.
8 September 2014Gastric GIST, wedge resection after neoadjuvant treatment
Before the imatinib era, the surgical treatment for locally advanced gastric GIST was associated with high rates of complications, or considered unresectable due to mandatory “en-bloc resection” of the tumor and the affected structures. Neoadjuvant treatment represent a revolution in the therapeutic field for the gastric GIST, making the difficult or impossible cases into feasible ones.